MX2009004962A - Metodo para tratar asma, rinitis alergia y trastornos de la piel. - Google Patents

Metodo para tratar asma, rinitis alergia y trastornos de la piel.

Info

Publication number
MX2009004962A
MX2009004962A MX2009004962A MX2009004962A MX2009004962A MX 2009004962 A MX2009004962 A MX 2009004962A MX 2009004962 A MX2009004962 A MX 2009004962A MX 2009004962 A MX2009004962 A MX 2009004962A MX 2009004962 A MX2009004962 A MX 2009004962A
Authority
MX
Mexico
Prior art keywords
skin disorders
allergic rhinitis
treating asthma
asthma
allergic
Prior art date
Application number
MX2009004962A
Other languages
English (en)
Inventor
Peter G Klimko
Clay Beauregard
Bryon S Severns
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of MX2009004962A publication Critical patent/MX2009004962A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)

Abstract

El uso de ácido 5,6,7-trihidroxiheptanoico y análogos se describe para el tratamiento de asma, rinitis alérgica y trastornos de la piel seleccionados del grupo que consiste en dermatitis alérgica, hipersensibilidad al contacto, urticaria (erupciones), rosácea y soriasis.
MX2009004962A 2006-11-07 2007-11-06 Metodo para tratar asma, rinitis alergia y trastornos de la piel. MX2009004962A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85733906P 2006-11-07 2006-11-07
PCT/US2007/083695 WO2008058098A2 (en) 2006-11-07 2007-11-06 Method of treating asthma, allergic rhinitis, and skin disorders

Publications (1)

Publication Number Publication Date
MX2009004962A true MX2009004962A (es) 2009-05-21

Family

ID=39276163

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004962A MX2009004962A (es) 2006-11-07 2007-11-06 Metodo para tratar asma, rinitis alergia y trastornos de la piel.

Country Status (12)

Country Link
US (2) US20080108695A1 (es)
EP (1) EP2079459A2 (es)
JP (1) JP2010509240A (es)
KR (1) KR20090086573A (es)
CN (1) CN101534806A (es)
AU (1) AU2007316482A1 (es)
BR (1) BRPI0718540A2 (es)
CA (1) CA2668645A1 (es)
MX (1) MX2009004962A (es)
TW (1) TW200829232A (es)
WO (1) WO2008058098A2 (es)
ZA (1) ZA200902909B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687539B1 (en) * 2005-11-07 2010-03-30 Alcon Research, Ltd. Method of treating ocular allergy
WO2011096941A1 (en) * 2010-02-08 2011-08-11 Alcon Research, Ltd. Method of treating ocular allergy
JP2013521230A (ja) * 2010-02-25 2013-06-10 アルコン リサーチ， リミテッド 角膜創傷治癒を促進する方法
CN110840878B (zh) * 2019-11-05 2020-06-26 牡丹江医学院 一种用于治疗银屑病的化合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286730A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory disease
FR2701477B1 (fr) * 1993-02-16 1995-03-31 Adir Nouveaux composés (cyclohexyl)alcéniques, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
US6887901B1 (en) * 1993-06-15 2005-05-03 Brigham & Women's Hospital, Inc. Lipoxin compounds and their use in treating cell proliferative disorders
ES2313715T3 (es) * 1993-06-15 2009-03-01 The Brigham And Women's Hospital, Inc. Compuestos de lipoxina con semivida prolongada.
US5430049A (en) * 1993-12-08 1995-07-04 Gaut; Zane N. Treating hyperproliferative disorders
SE9601677D0 (sv) * 1996-05-02 1996-05-02 Scotia Lipidteknik Ab New use
US6831186B2 (en) * 2001-11-06 2004-12-14 Schering Aktiengesellschft Lipoxin A4 analogs
US8815950B2 (en) * 2003-08-29 2014-08-26 Janssen Biotech, Inc. Pharmaceutical compositions and method of using levodopa and carbidopa
US20050203184A1 (en) * 2003-09-10 2005-09-15 Petasis Nicos A. Benzo lipoxin analogues
ZA200703992B (en) * 2004-11-09 2009-08-26 Alcon Inc 5, 6, 7-Trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses

Also Published As

Publication number Publication date
ZA200902909B (en) 2010-07-28
BRPI0718540A2 (pt) 2013-11-19
WO2008058098A3 (en) 2008-08-07
CN101534806A (zh) 2009-09-16
US20080108695A1 (en) 2008-05-08
EP2079459A2 (en) 2009-07-22
KR20090086573A (ko) 2009-08-13
TW200829232A (en) 2008-07-16
AU2007316482A1 (en) 2008-05-15
US20090156667A1 (en) 2009-06-18
WO2008058098A2 (en) 2008-05-15
CA2668645A1 (en) 2008-05-15
JP2010509240A (ja) 2010-03-25

Similar Documents

Publication Publication Date Title
WO2012083132A3 (en) Diagnosis and treatments relating to th2 inhibition
WO2009050506A3 (en) Combination 059
MX2019003821A (es) Composiciones de aminoacidos y usos de las mismas.
BR112013004768A2 (pt) dispositivos e métodos para dilatar uma abertura de seio parasanal e para o tratamento de sinusite
MY148985A (en) 2-aminopyridine analogs as glucokinase activators
DE602006007093D1 (de) Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden
WO2007130474A3 (en) Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
SG179410A1 (en) Therapeutic uses of inhibitors of rtp801
IL214373A0 (en) Use of adipose tissue-derived cells in the preparation of a composition for the treatment of cardiovascular diseases
EA200702387A1 (ru) Имидазохинолины в качестве ингибиторов липидкиназы
WO2005116088A3 (en) Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells
MX2012000034A (es) Metodos para el tratamiento o la prevencion de la fatiga.
MX2009005725A (es) Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13.
WO2008096203A3 (en) Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
WO2008033440A3 (en) Treatment of hyperproliferative diseases with anthraquinones
EP3712264A8 (en) Cystathionine beta-synthase enzyme for treatment of homocystinuria
EA201490795A1 (ru) 3,4-дизамещенное пиридиновое соединение, способы применения и содержащие его композиции
TN2009000503A1 (en) Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
WO2010097788A3 (en) Visfatin therapeutic agents for the treatment of acne and other conditions
EP2563794A4 (en) INHIBITORS OF TYROSINE KINASE PROTEIN ACTIVITY AND THEIR APPLICATIONS TO THE TREATMENT OF OPHTHALMIC DISORDERS
EA201170672A1 (ru) Соединения, пригодные для лечения целлюлита
MX2013002121A (es) Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2009004962A (es) Metodo para tratar asma, rinitis alergia y trastornos de la piel.
ATE448779T1 (de) Methode zur behandlung trockener augen und uveitis
MX2010009488A (es) Métodos para modular la actividad del receptor de mc5, y tratamiento de las afecciones relacionadas con este receptor.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal